Kusurinomadoguchi Inc. (5592) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kusurinomadoguchi Inc. (5592:JPX), powered by AI.

Current Price
¥2,495
P/E Ratio
13.8
Market Cap
28.0B
Sector
Healthcare
What is the Kusurinomadoguchi Inc. stock price forecast?

Kusurinomadoguchi Inc. is currently trading at ¥2,495. View real-time AI analysis on Alpha Lenz.

What is Kusurinomadoguchi Inc. insider trading activity?

View the latest insider trading data for Kusurinomadoguchi Inc. on Alpha Lenz.

What is Kusurinomadoguchi Inc.'s P/E ratio?

Kusurinomadoguchi Inc.'s P/E ratio is 13.8.

Kusurinomadoguchi Inc.

JPX · 5592
¥2,495-52(-2.04%)Market closedJPX regular session 09:00–15:00 JST
Ask about Kusurinomadoguchi Inc.'s future dividend policy...
Alpha Chat Insight

Kusurinomadoguchi Inc. trades at a P/E of 13.8 (undervalued) with strong ROE of 27.5%. 3Y revenue CAGR of 19.9% highlights clear growth momentum.

Ask for details

Company Overview

Kusurinomadoguchi Inc. is a leading company specializing in healthcare solutions, focusing primarily on the distribution and provision of pharmaceutical services. The company operates a network of pharmacies that offer prescription medications, health consultations, and over-the-counter healthcare products. With a commitment to enhancing community health, Kusurinomadoguchi collaborates with healthcare professionals to ensure high-quality service delivery and patient care. The company plays a vital role in the pharmaceutical industry, impacting sectors such as retail pharmaceuticals, healthcare services, and health technology. Its comprehensive range of services includes medication management, health screenings, and wellness counseling, catering to diverse consumer needs. Kusurinomadoguchi Inc. not only facilitates access to essential medications but also serves as a healthcare partner to its patrons. In the financial market, Kusurinomadoguchi Inc. is recognized for its robust market presence and its contributions to advancing healthcare access and services. Headquartered in Japan, it leverages advanced technology platforms to optimize pharmacy operations and foster personalized healthcare journeys for its customers. The company's focus on innovation and consumer-centric strategies positions it as a cornerstone in the evolving landscape of retail health services.

CEOMr. Nobuaki Tanaka
SectorHealthcare
IndustryHealth Information Services
Employees484

Company Statistics

FY 2025

Profile

¥28,031,772,600Market Cap
¥11,199,409,000Revenue
0.00Shares Out
484Employees

Margins

57.82%Gross
29.06%EBITDA
17.45%Operating
14.78%Pre-Tax
18.50%Net

Valuation

13.78P/E
3.32P/B
2.50EV/Sales
8.01EV/EBITDA
-3.93P/FCF

Growth (CAGR)

19.95%Rev 3Yr
N/ARev 5Yr
39.81%Op Inc 3Yr
N/AOp Inc 5Yr
48.99%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

11.76%ROA
27.46%ROE
9.43%ROIC

Financial Health

¥2,104,095,000Cash & Cash Equivalents
¥1,536,383,000Net Debt
42.74%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kusurinomadoguchi Inc. (ticker: 5592) is a company listed on JPX in the Healthcare sector (Health Information Services). It has approximately 484 employees. Market cap is $28.0B.

The current price is 2,495 with a P/E ratio of 13.78x and P/B of 3.32x.

ROE is 27.46% and operating margin is 17.45%. Annual revenue is $11.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kusurinomadoguchi Inc. (5592) Stock Forecast 2026 ¥2,495 — Price, Financials & Analyst Targets | Alpha Lenz